Search IPOs
NEOCHEM · NSE · Specialty Chemicals
Neochem Bio Solutions IPO listed on 09 Dec 2025 on NSE at ₹108.00, a gain of 10.20% over the issue price of ₹98.00. The IPO was subscribed 15.59x overall.
Neochem Bio Solutions IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | 02 Dec 2025 |
| IPO Close Date | 04 Dec 2025 |
| Basis of Allotment | 05 Dec 2025 |
| Initiation of Refunds | 08 Dec 2025 |
| Credit of Shares to Demat | 08 Dec 2025 |
| Listing Date | 09 Dec 2025 |
Listing day gain
+10.2%
Listed at ₹108 (issue ₹98)
Issue
₹98
Listing
₹108
Current
₹111.8
+14.08% vs issue
Day range
₹102.6 – ₹113.4
Issue Size
4,588,800 shares
(aggregating up to ₹45.00 Cr)
Issue Price
₹93 – ₹98
Face Value
₹10/share
Market Lot
1,200 shares
Retail Min Investment
₹235,200
Listing At
NSE
Sale Type
fresh issue
Fresh Issue
4,588,800 shares
(aggregating up to ₹45 Cr)
Offer for Sale
[.]
Reserved for Market Maker
232,800 shares
(aggregating up to ₹2.00 Cr)
Issue Type
book building
Open Date
02 Dec
Close Date
04 Dec
Allotment
05 Dec
Listing
09 Dec
Last updated: 9 months ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 08 Dec 2025 Latest | ₹98 | ₹2 | ₹100 | ₹2 |
2.04%
|
11:38 AM |
| 07 Dec 2025 | ₹98 | ₹10 | ₹108 | ₹10 |
10.2%
|
11:38 AM |
Showing the 2 most recent GMP entries.
View full GMP historyLatest snapshot: 04 Dec 2025
| Category | Subscribed (x) | No. of Applications |
|---|---|---|
| QIB | 21.97x | 27 |
| NII | 21.5x | 1,629 |
| bNII (bids above ₹10L) | 26.31x | 964 |
| sNII (bids below ₹10L) | 11.88x | 665 |
| Individual Investors | 9.42x | 5,990 |
| Total | 15.59x | 9,275 |
Showing the latest subscription snapshot.
View full subscription historySwapnil Rameshbhai Makati and Hemangini Swapnil Dathia are the promoters of the company.
New to lot sizes and investment limits? Read our guide on IPO lot size and minimum investment.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 2,400 | ₹235,200 |
| Retail (Max) | 2 | 2,400 | ₹235,200 |
| S-HNI (Min) | 3 | 3,600 | ₹352,800 |
| S-HNI (Max) | 8 | 9,600 | ₹940,800 |
| B-HNI (Min) | 9 | 10,800 | ₹1,058,400 |
Want to understand how IPO shares are divided between investor categories? Read our guide on IPO reservation structure.
| Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 232,800 (5.07%) |
| QIB Shares Offered | 2,174,400 (47.39%) |
|
•
Anchor Investor Shares Offered
|
1,303,200 (28.40%) |
|
•
QIB (Ex. Anchor) Shares Offered
|
871,200 (18.99%) |
| NII (HNI) Shares Offered | 655,200 (14.28%) |
|
•
bNII > ₹10L
|
436,800 (9.52%) |
|
•
sNII < ₹10L
|
218,400 (4.76%) |
| Retail Shares Offered | 1,526,400 (33.26%) |
| Total Shares Offered | 4,588,800 (100.00%) |
Neochem Bio Solutions is an Ahmedabad-based specialty chemical manufacturer. They produce a wide variety of performance chemicals—over 350 formulations—used in industries like textiles, home and personal care, water treatment, and construction. They operate a large 22,000 MTPA facility and focus on eco-friendly, bio-based solutions.
Strength:
The company’s core strength lies in its diverse product portfolio which spans four major segments: Polymers, Surfactants, Silicones, and Bio-based Esters. This variety allows them to serve multiple industries, reducing dependence on a single sector. They have a state-of-the-art manufacturing unit in Moraiya, Ahmedabad, which is equipped with an in-house R&D lab for creating customized formulations. Their "Zero Liquid Discharge" (ZLD) facility and focus on green chemistry give them a competitive edge in an increasingly environmentally conscious global market. Furthermore, they maintain long-term relationships with a broad customer base, ensuring steady demand for their textile and garment washing auxiliaries.
Growth:
Neochem has shown explosive financial growth, with its Profit After Tax (PAT) surging by 330% between FY24 and FY25. This growth is driven by a shift toward high-margin, value-added products and better capacity utilization. The company is strategically using the IPO proceeds to fund its long-term working capital and reduce debt, which will improve liquidity and allow for further scaling of operations. As global players look for reliable "China Plus One" alternatives, Neochem is well-positioned to capture a larger share of the specialty formulation market both in India and internationally.
Standalone · ₹ in Crores
| Particulars | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Total Revenue | 48.79 | 62.01 | 86.15 |
| Profit After Tax (PAT) | 1.07 | 1.8 | 7.75 |
| EBITDA | 4.23 | 5.99 | 13.11 |
| Total Assets | 50.6 | 64.06 | 78.89 |
| Net Worth | 8.05 | 12 | 19.75 |
| Reserves & Surplus | 2.63 | 5.33 | 13.08 |
| Total Borrowing | 26.24 | 33.32 | 35.62 |
Revenue & Profit Trend
The basis of allotment for Neochem Bio Solutions IPO was finalised on 05 Dec 2025. You can check your allotment status using your PAN number or application number on the MUFG Intime India Pvt.Ltd portal or BSE.
The Neochem Bio Solutions IPO is expected to open in Dec 2025, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Neochem Bio Solutions IPO is ₹93.00 - ₹98.00 per share.
As per market sources, Neochem Bio Solutions IPO GMP is currently ₹2.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Neochem Bio Solutions IPO stands at 15.59x overall.
The listing date for Neochem Bio Solutions IPO is 09 Dec 2025.
No comments yet. Be the first to comment!
